Don Stewart
Chief Executive Officer
PlantForm
Biosimilars Commercialisation Summit Agenda 2019
Conference Day One
Wednesday, February 5th, 2020
10:10 AM Panel Discussion: Exploring the Sensitivity and Complexity of the North American Biosimilars Market
- Overcome the current battle to combat misinformation surrounding biosimilars in the US, and the essential methods to boost stakeholder confidence, in the face of immense competition from biologics
- Discuss the current regulatory landscape with respect to the FDA Biosimilar Action Plan and the newly published regulatory framework regarding the use of real world evidence and real world data
- Explore the game-changing concept of the ‘Purple Book’ for pharmacists, asking “Does this make either medical or commercial logic?”
11:25 AM Case Study: Cracking the Canadian Market and Breaking into Brazil
- Explore the novel and low cost method of using plants in the development and manufacture of biosimilars
- Discover how PlantForm was able to maximise success in the conservative Canadian market and break into Brazil
- Looking to the future: prospects for PlantForm in China, India and South Africa, considering regulatory differences and market access strategy